CRISIL ESG Rates Rainbow Childrens Medicare Limited; ESG Score Improves to 61

CRISIL ESG Rates Rainbow Childrens Medicare Limited; ESG Score Improves to 61

CRISIL ESG Rates Rainbow Childrens Medicare Limited; ESG Score Improves to 61​

Rainbow Childrens Medicare Limited has received an ESG rating from CRISIL ESG Rating & Analytics Limited (CRISIL ESG) based on its performance during Fiscal Year 2025-26. The ratings were assigned following the independent assessment by CRISIL ESG, which conducted the review using publicly available data for the specified fiscal year.

The company's overall Environmental, Social and Governance (ESG) rating was assigned as 61. Furthermore, it received a Core ESG rating of 73 for FY 2025-26.

This new ESG rating reflects a notable improvement in the company’s standing compared to previous years. The current rating positions the company's overall ESG status from "Adequate" to 'Strong', referencing the ratings assigned during Fiscal Years 2024-25 and 2023-24.

The assessment carried out by CRISIL ESG was an independent undertaking, as the Company had not engaged CRISIL ESG specifically for obtaining ESG Ratings. The data used in the report pertain solely to FY 2025-26 and were sourced from the public domain.

Key ESG rating details for Rainbow Childrens Medicare Limited are summarized below:

Rating MetricFiscal Year (FY)Assigned ValueKey Status Change
Overall ESG Rating2025-2661Improved from "Adequate" to 'Strong'
Core ESG Rating2025-2673N/A

RAINBOW Stock Price Movement​

Shares of Rainbow Childrens Medicare Limited are slipping by 1.06% in live trading as of 12:36 PM, currently at ₹1474.1. The equity has seen 18,330 shares traded so far, keeping the stock hovering near its daily low of ₹1471.
 

Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.

The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.

Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.

Back
Top